Company Monitoring Page for GSK

latest headlines for company on cafepharma

GSK still has a crush on oligonucleotides, sealing the deal with Elsie
Fierce Biotech
Wed, 02/14/24 - 10:53 am
Tags:
GSK, oligonucleotides, Elsie Biotechnologies
FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen
Pharmaphorum
Mon, 02/12/24 - 10:28 am
Tags:
GSK, FDA, fast track, hepatitis B, bepirovirsen, antisense
GSK reports positive news on trio of high-profile products
Medical Marketing and Media
Wed, 02/7/24 - 09:13 pm
Tags:
GSK, Arexvy, RSV, Abrysvo, Blenrep
GSK’s Blenrep Combo Scores Phase III Win in Multiple Myeloma
BioSpace
Tue, 02/6/24 - 09:25 am
Tags:
GSK, Blenrep, Multiple Myeloma, clinical trials
GSK’s Arexvy Leads Over Pfizer’s Abrysvo in Year One of RSV Vaccine Market Battle
Xtalks
Mon, 02/5/24 - 11:12 pm
Tags:
GSK, Pfizer, RSV, Arexvy, Abrysvo, vaccines
GSK sees strong growth as Haleon split and vaccine drive pays off
Reuters
Wed, 01/31/24 - 11:53 am
Tags:
GSK, earnings, Haleon, vaccines
GSK confirms Arexvy is a blockbuster but says the RSV battle has just begun
Fierce Pharma
Wed, 01/31/24 - 11:49 am
Tags:
GSK, Pfizer, RSV, vaccines, Arexvy
GSK RSV vaccine achieves blockbuster status in just over six months
Tip Ranks
Mon, 01/29/24 - 10:30 pm
Tags:
GSK, RSV, vaccines, Arexvy, Pfizer
After GSK and Novartis handoffs, Laekna's drug fails ovarian cancer trial
Fierce Biotech
Mon, 01/29/24 - 10:27 pm
Tags:
Laekna, afuresertib, clinical trials, ovarian cancer, GSK, Novartis
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Tags:
Synnovation Therapeutics, Incyte, AstraZeneca, GSK, Novartis, Pfizer, funding, cancer, PARP inhibitors
Next stage in GSK’s Zantac defense gets underway today
Pharmaphorum
Mon, 01/22/24 - 11:13 am
Tags:
GSK, Zantac, legal, cancer
GSK raises $1.24 bln from latest Haleon stake sale
Reuters
Wed, 01/17/24 - 09:22 am
Tags:
GSK, consumer health, Haleon, spinoffs
GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline
BioSpace
Tue, 01/9/24 - 09:50 am
Tags:
GSK, Aiolos Bio, M&A, asthma, JPMHC 2024
Curevo’s shingles vaccine equals GSK’s Shingrix in phase 2 head-to-head
Fierce Biotech
Tue, 01/9/24 - 09:47 am
Tags:
Curevo Vaccine, GSK, shingles, vaccines, Shingrix
GSK amends commercial deal with Scynexis as antifungal recall drags into 2024
Fierce Pharma
Wed, 01/3/24 - 04:57 pm
Tags:
GSK, Scynexis, Brexafemme, antifungals
GSK heads back to Hansoh, paying $185M upfront for another ADC
Fierce Biotech
Wed, 12/20/23 - 09:46 am
Tags:
GSK, Hansoh Pharmaceutical, antibody-drug conjugate
GSK's cancer drug combination meets primary goal in late-stage trial
Reuters
Mon, 12/18/23 - 10:10 am
Tags:
GSK, Zejula, Jemperli, endometrial cancer, clinical trials
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
BioSpace
Fri, 12/1/23 - 11:30 am
Tags:
GSK, Pfizer, RSV, vaccines, Arexvy
GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year
Reuters
Thu, 11/30/23 - 11:12 pm
Tags:
GSK, RSV, vaccines, Emma Walmsley, Pharma CEOs
After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset
Fierce Biotech
Thu, 11/30/23 - 10:07 am
Tags:
Merck, GSK, chronic cough, Bellus Health, gefapixant, Camlipixant

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.